127
Participants
Start Date
September 30, 2009
Primary Completion Date
June 30, 2011
Study Completion Date
January 31, 2013
Etanercept
Etanercept 0.8 mg/kg QW up to a maximum dose of 50 mg
Pfizer Investigational Site, Ljubljana
Pfizer Investigational Site, Riga
Pfizer Investigational Site, Budapest
Pfizer Investigational Site, Brussels
Pfizer Investigational Site, Westmead, Sydney
Pfizer Investigational Site, Leuven
Pfizer Investigational Site, Parkville, Melbourne
Pfizer Investigational Site, Ghent
Pfizer Investigational Site, Belgrade
Pfizer Investigational Site, Berlin
Pfizer Investigational Site, Niš
Pfizer Investigational Site, Hamburg
Pfizer Investigational Site, Madrid
Pfizer Investigational Site, Madrid
Pfizer Investigational Site, Bremen
Pfizer Investigational Site, Hanover
Pfizer Investigational Site, Valencia
Pfizer Investigational Site, Sankt Augustin
Pfizer Investigational Site, Chieti
Pfizer Investigational Site, Paris
Pfizer Investigational Site, Paris
Pfizer Investigational Site, Le Kremlin-Bicêtre
Pfizer Investigational Site, Moscow
Pfizer Investigational Site, Saint Petersburg
Pfizer Investigational Site, Barranquilla
Pfizer Investigational Site, Bucaramanga
Pfizer Investigational Site, Bogota
Pfizer Investigational Site, Brno
Pfizer Investigational Site, Prague
Pfizer Investigational Site, Prague
Pfizer Investigational Site, Riga
Pfizer Investigational Site, Vilnius
Pfizer Investigational Site, Mexico City
Pfizer Investigational Site, Utrecht
Pfizer Investigational Site, Oslo
Pfizer Investigational Site, Krakow
Pfizer Investigational Site, Wroclaw
Pfizer Investigational Site, Bydgoszcz
Pfizer Investigational Site, Warsaw
Pfizer Investigational Site, Košice
Pfizer Investigational Site, Piešťany
Pfizer Investigational Site, Esplugues de Llobregat
Lead Sponsor
Pfizer
INDUSTRY